Hearing News Watch

Featured image for “Phonak Sponsors Student Education Grant for 2025 Future of Hearing Healthcare Conference”
May. 01, 2025

Phonak Sponsors Student Education Grant for 2025 Future of Hearing Healthcare Conference

HHTM
Emerging hearing care professionals will once again have the opportunity to participate in one of the field’s most forward-looking events, thanks to the support of Phonak. As the sponsor of this year’s Student Education Grant, Phonak will provide up to 100 students pursuing degrees in audiology, hearing science, or related disciplines with complimentary access to the 2025 Future of Hearing
Featured image for “Legislation Introduced to Include Hearing Aid Specialists in VA Community Care Program”
May. 01, 2025

Legislation Introduced to Include Hearing Aid Specialists in VA Community Care Program

HHTM
WASHINGTON, D.C. – A new bill introduced in the U.S. House of Representatives aims to include Hearing Aid Specialists as eligible providers under the Department of Veterans Affairs (VA) Community Care program. The bill, titled the Veterans Hearing Health Expansion Act (H.R. 3088), was introduced by Rep. Tom Barrett (R-MI) on April 30, 2025. If passed, the legislation would amend
Featured image for “Acousia Therapeutics Reaches 50% Enrollment in Phase 2 PROHEAR Study Evaluating Hearing Loss Prevention in Cancer Patients”
Apr. 30, 2025

Acousia Therapeutics Reaches 50% Enrollment in Phase 2 PROHEAR Study Evaluating Hearing Loss Prevention in Cancer Patients

HHTM
Tübingen, Germany – Acousia Therapeutics GmbH announced it has reached the 50% enrollment milestone in its ongoing Phase 2 clinical trial, known as the PROHEAR Study. The trial is evaluating ACOU085 (INN: bimokalner), a Kv7.4 channel activator, for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is widely used in modern oncology, with more
Featured image for “Lenire Tinnitus Device Shows Success in Real-World Clinical Study”
Apr. 30, 2025

Lenire Tinnitus Device Shows Success in Real-World Clinical Study

HHTM
CHICAGO, ILLINOIS — Nature Communications Medicine has published a peer-reviewed study showcasing real-world evidence for the effectiveness of Lenire, the FDA-approved tinnitus treatment device. The study reports that 91.5% of patients experienced clinically significant reductions in tinnitus after 12 weeks of treatment. With data from 220 patients, this study represents one of the largest real-world analyses of tinnitus patients to
Featured image for “Amplifon Adds Arizona-Based Clinics in Latest U.S. Expansion”
Apr. 29, 2025

Amplifon Adds Arizona-Based Clinics in Latest U.S. Expansion

HHTM
MILAN, ITALY – Amplifon has announced the acquisition of two companies in the United States: Safe in Sound Hearing, LLC and SISH Tucson, LLC. Together, these companies operate 24 locations in Arizona and were previously the fourth largest franchisee of Miracle-Ear, the brand through which Amplifon operates in the U.S. The acquired businesses generate combined annual revenues of over $15
Featured image for “Dr. John Oghalai Receives NIH Grant to Advance Noninvasive Imaging of the Human Inner Ear”
Apr. 27, 2025

Dr. John Oghalai Receives NIH Grant to Advance Noninvasive Imaging of the Human Inner Ear

HHTM
LOS ANGELES, CALIFORNIA — Dr. John Oghalai, Chair of Otolaryngology–Head and Neck Surgery at the Keck School of Medicine of USC, has been awarded a prestigious R01 grant from the National Institutes of Health (NIH) to further his research into noninvasive imaging of the human inner ear using optical coherence tomography (OCT). The project, titled “OCT Imaging of the Human
Featured image for “Fifth Annual Future of Hearing Healthcare Conference to Take Place May 14, 21, and 28, 2025”
Apr. 24, 2025

Fifth Annual Future of Hearing Healthcare Conference to Take Place May 14, 21, and 28, 2025

HHTM
The fifth annual Future of Hearing Healthcare Conference (FHH) will be held virtually on May 14, 21, and 28, continuing its mission to highlight the ideas, innovations, and individuals shaping the future of hearing care. Organized by Hearing Health & Technology Matters (HHTM), the three-day event will feature expert-led sessions and live panel discussions addressing clinical best practices, new technologies,
Featured image for “Paul Simon Opens Up About Hearing Loss, Music, and Meaning in New Starkey Sound Bites Interview”
Apr. 24, 2025

Paul Simon Opens Up About Hearing Loss, Music, and Meaning in New Starkey Sound Bites Interview

HHTM
EDEN PRAIRIE, MINNESOTA – Grammy-winning singer-songwriter Paul Simon shares his personal journey with hearing loss in a new episode of Starkey Sound Bites, hosted by Starkey’s Chief Hearing Health Officer, Dr. Dave Fabry. The candid interview offers a rare glimpse into how Simon has navigated the emotional and professional impact of sudden hearing loss, and how it continues to influence
Featured image for “Good Vibrations Day Returns to Raise Awareness for Bone Anchored Hearing”
Apr. 24, 2025

Good Vibrations Day Returns to Raise Awareness for Bone Anchored Hearing

HHTM
SOMERSET, NEW JERSEY – Oticon Medical is marking the fifth annual Good Vibrations Day, a global initiative dedicated to raising awareness of bone anchored hearing. The month-long campaign includes social media outreach and in-office celebrations around the world, culminating on May 3, a date chosen to honor the birthday of Per-Ingvar Brånemark, the Swedish physician widely recognized as the father
Featured image for “Amplifon Confirms Leadership, Reports 2024 Financials, and Earns Climate Recognition”
Apr. 24, 2025

Amplifon Confirms Leadership, Reports 2024 Financials, and Earns Climate Recognition

HHTM
MILAN, ITALY — Amplifon S.p.A., a global provider of hearing care solutions, has announced a series of developments this month, including confirmation of its leadership, approval of 2024 financial statements, and recognition for its climate efforts. Leadership and Governance Confirmed Following Shareholder Meeting Following the shareholders’ meeting on April 23, the newly appointed Board of Directors met to confirm the